Barriers to Blood Cancer Treatment and Rising Use of Hospice Care
Published
A report in South Korea has pointed out several barriers to treatment for patients with blood cancer. A medical news outlet reported that criminal risks, drug prices that cause losses, and problems with national health insurance coverage are blocking patients' access to treatment.
The report is based on the contents of an annual report. According to the report, the number of new patients using hospice care in 2025 was 26,020, which is 1,702 more than the 24,318 in 2024. In 2023, the number was 22,394, so new hospice patients have increased for three years in a row.
Hospice care is a service that helps patients with serious illness who are difficult to treat to reduce pain and live in comfort. The rise in new users can be seen as a sign that more seriously ill patients are looking for this service. However, the report does not explain all the specific causes of this increase.
Institutional problems related to blood cancer treatment are still being discussed. Medical professionals and patient groups are calling for changes to the system so that new treatments can have fair prices and insurance benefits. People are watching closely to see what measures the government and related agencies will announce next.
Sources: 코리아헬스로그
More South Korea news
- Korean Stock Market on November 20: What Were the Top 50 Gainers?
- AI and Digital Technology Are Changing Daily Life: 2026 Government Innovation Expo Opens at KINTEX on the 25th
- President Trump Regrets That Immigration Crackdown Was Too Harsh, but Tightens Rules Further
- US Air Taxi Company Joby Sees Revenue Rise in Third Quarter
- K-EnterTech Hub Releases Free Preview Guide for CES 2027
- Democrats Take Control of Both Houses in U.S. Midterm Elections
- What Should We Learn from North Korea Diplomacy?
- Domestic Investors Call for Better Overseas Stock Capital Gains Tax as Tesla and SpaceX Merger Possibility Emerges